Location History:
- Eden Prairie, MN (US) (2018)
- Eden Prairie, MO (US) (2020)
- Minneapolis, MN (US) (2020 - 2023)
Company Filing History:
4 out of 2,310 
1 out of 987 
1 out of 873 
Years Active: 2018-2023
Title: Innovations of Zhengqiang Wang
Introduction
Zhengqiang Wang is a notable inventor based in Eden Prairie, MO (US). He has made significant contributions to the field of antiviral compounds and has been awarded 4 patents for his innovative work. His research focuses on developing compounds that target viral infections, particularly HIV and hepatitis B.
Latest Patents
Wang's latest patents include groundbreaking inventions such as antiviral compounds that provide a compound of formula I, formula II, or formula III, or a salt thereof. These compounds are designed to be effective as HIV-1 CA-targeting molecules and as antiviral agents. Another significant patent involves inhibitors of the hepatitis B virus that target capsid assembly, offering novel compounds and methods for treating, preventing, or inhibiting HBV.
Career Highlights
Throughout his career, Zhengqiang Wang has worked with prestigious institutions, including the University of Minnesota and Emory University. His research has contributed to advancements in antiviral therapies, showcasing his commitment to improving public health through innovation.
Collaborations
Wang has collaborated with esteemed colleagues, including Stefanos G Sarafianos and Stefan G Sarafianos, further enhancing the impact of his research in the scientific community.
Conclusion
Zhengqiang Wang's contributions to antiviral research and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments and therapies for viral infections.